# A Study in the Treatment of Acute Mania

> **NCT00767715** · PHASE4 · TERMINATED · sponsor: **Eli Lilly and Company** · enrollment: 11 (actual)

## Conditions studied

- Bipolar Disorder

## Interventions

- **DRUG:** olanzapine
- **DRUG:** haloperidol
- **DRUG:** zuclopentixol

## Key facts

- **NCT ID:** NCT00767715
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2004-10
- **Primary completion:** 2005-04
- **Final completion:** 2005-04
- **Target enrollment:** 11 (ACTUAL)
- **Why stopped:** Trial discontinued due to low enrollment
- **Last updated:** 2008-10-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00767715

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00767715, "A Study in the Treatment of Acute Mania". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00767715. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*